ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,699, issued on Jan. 20, was assigned to REGENERON PHARMACEUTICALS INC (Tarrytown, N.Y.) and VYRIAD INC. (Rochester, Minn.).
"Detection assays for coronavirus neutralizing antibodies" was invented by Stephen J. Russell (Rochester, Minn.), Kah Whye Peng (Rochester, Minn.), Patrycja Lech (Rochester, Minn.), Rianna Vandergaast (Rochester, Minn.) and Timothy Carey (Rochester, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides methods for determining the presence of coronavirus neutralizing antibodies in a sample as well as associated compositions and kits. The methods of the disclosure use recombinant vesicular stomatitis virus ...